Basics of LC and LC/MS Analysis of Nucleic Acid Pharmaceuticals

In recent years, nucleic acid medicines, a type of biopharmaceutical, have gained widespread attention. However, ensuring stability and efficacy in their development poses challenges, increasing the importance of analytical techniques. This webinar will provide a detailed explanation of the current state of biopharmaceuticals, the fundamentals of nucleic acid medicines, know-how on LC/MS analysis, and the market situation. We aim to provide valuable information for those who are looking to conduct nucleic acid medicine analysis.
<Program>
"Technical Challenges and Solutions for Nucleic Acid Medicines: Introduction"
Yoshitaka Suzawa, Agilent Technologies, Inc.
Recently, there has been an increase in the practical application of new modalities, including nucleic acid medicines. This presentation will overview the current state and technical challenges of nucleic acid medicines and introduce Agilent's innovative solutions.
"Ready to Use! Know-How and Basics of LC/LC-MS Analysis for Nucleic Acid Medicines"
Akio Hayashi, Agilent Technologies, Inc.
With the depletion of resources for small molecule drugs, oligonucleotides have recently attracted attention as a new modality. This webinar will explain the differences between oligonucleotide medicines and small molecule analysis, starting from the basics to the know-how and the reasons behind it.


Date and time | Wednesday, Jul 30, 2025 03:00 PM ~ 04:00 PM |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration